Find clinical trials for Diabetes in Warszawa, Mazowieckie
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Warszawa, Mazowieckie, POL:
months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...
Warsaw, Poland and 7 other locations
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to pl...
Phase 3
Warsaw, Poland and 217 other locations
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Warsaw, Masovian Voivodeship, Poland and 47 other locations
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to placebo on:*...
Phase 3
Warsaw, Poland and 115 other locations
The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...
Phase 3
Warsaw, Poland and 59 other locations
study medicine to help adults with obesity or overweight and type 2 diabetes lose weight. Being overweight or obese means carrying too much ...
Phase 3
Warsaw, Poland and 183 other locations
Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term effic...
Phase 3
Warsaw, Poland and 135 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Płońsk, Poland and 228 other locations
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3
Warsaw, Poland and 186 other locations
parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...
Phase 2
Warsaw, Poland and 69 other locations
Clinical trials
Research sites
Resources
Legal